Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Invernizzi

Showing results (251-260 of 420) with videos related to

Pageof 42
Sort By:
The American Journal of Pathology|January 15, 2017
miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma ProliferationLaurent Ehrlich, Chad Hall, Julie Venter, et al.
Journal of Autoimmunity|February 5, 2013
Y chromosome loss in male patients with primary biliary cirrhosisAna Lleo, Sabine Oertelt-Prigione, Ilaria Bianchi, et al.
Hepatology (Baltimore, Md.)|March 31, 2018
Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2<sup>-/-</sup> mice and human cholangiocarcinoma tumorigenesisLindsey Kennedy, Laura Hargrove, Jennifer Demieville, et al.
Journal of Autoimmunity|September 3, 2015
Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathwaysKelly Hudspeth, Matteo Donadon, Matteo Cimino, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2019
Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinomaSilvestre Vicent, Ruby Lieshout, Anna Saborowski, et al.
Journal of Hepatology|January 13, 2005
Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosisDomenico Alvaro, Pietro Invernizzi, Paolo Onori, et al.
Journal of Personalized Medicine|October 27, 2022
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary CholangitisAlessio Gerussi, Damiano Verda, Claudio Cappadona, et al.
The American Journal of Gastroenterology|September 30, 2015
Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'Ulrich Beuers, M Eric Gershwin, Robert G Gish, et al.
Hepatology (Baltimore, Md.)|September 16, 2015
Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'Ulrich Beuers, M Eric Gershwin, Robert G Gish, et al.
Hepatology (Baltimore, Md.)|May 21, 2014
Shotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cellsAna Lleo, Weici Zhang, W Hayes McDonald, et al.
Pageof 42

Showing results (251-260 of 420) with videos related to

Sort By:
Pageof 42
The American Journal of Pathology|January 15, 2017
miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma ProliferationLaurent Ehrlich, Chad Hall, Julie Venter, et al.
Journal of Autoimmunity|February 5, 2013
Y chromosome loss in male patients with primary biliary cirrhosisAna Lleo, Sabine Oertelt-Prigione, Ilaria Bianchi, et al.
Hepatology (Baltimore, Md.)|March 31, 2018
Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2<sup>-/-</sup> mice and human cholangiocarcinoma tumorigenesisLindsey Kennedy, Laura Hargrove, Jennifer Demieville, et al.
Journal of Autoimmunity|September 3, 2015
Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathwaysKelly Hudspeth, Matteo Donadon, Matteo Cimino, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2019
Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinomaSilvestre Vicent, Ruby Lieshout, Anna Saborowski, et al.
Journal of Hepatology|January 13, 2005
Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosisDomenico Alvaro, Pietro Invernizzi, Paolo Onori, et al.
Journal of Personalized Medicine|October 27, 2022
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary CholangitisAlessio Gerussi, Damiano Verda, Claudio Cappadona, et al.
The American Journal of Gastroenterology|September 30, 2015
Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'Ulrich Beuers, M Eric Gershwin, Robert G Gish, et al.
Hepatology (Baltimore, Md.)|September 16, 2015
Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'Ulrich Beuers, M Eric Gershwin, Robert G Gish, et al.
Hepatology (Baltimore, Md.)|May 21, 2014
Shotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cellsAna Lleo, Weici Zhang, W Hayes McDonald, et al.
Pageof 42